Decision-making places in Alzheimer’s dementia – Study part 1: Supporting health-related advance care planning

Not Applicable

• Conditions: F00; F01; F02; F03; F06.7; Dementia in Alzheimer disease; Dementia in other diseases classified elsewhere; Vascular dementia; Unspecified dementia; Mild cognitive disorder

• Registration Number: DRKS00026691
• Lead Sponsor: niversität Siegen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-10-15
• Study Completion: 2023-02-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 289

Inclusion Criteria

new Memory Clinic patient with suspected dementia. The inclusion process will rely on the decision tree for the incusion into medical research of persons inable to consent by Scholten et al. (in preparation) in order to include, where possible, individuals for whom capacity to consent is no longer certain

Exclusion Criteria

severe dementia, delirium, intellectual disability, severe psychiatric illness, insufficient ability to consent to medical research with concurrent inability for supported decisicion making by a relative or other proxy, uncompensated sensoric deficits, insufficient command of the German language preventing the understanding of the study documents or the interview

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
proportion of valid advance directives as assessed by a studyspecific questionnaire. We assess a.) the existence of an advance directive, as well as b.) its validity. Validity is assessed by the following cirteria: adequate information (Has counceling by a physician taken place? Has counceling by a notary taken place?), ability to consent (Has your ability to consent been documented by the physiscian or notary at the time when the advance directive was issued?), voluntariness (Have you made the advance directive voluntarily?). The answers to these questions are assessed at both assessments, T1 and T2 (see above).

Secondary Outcome Measures

Name	Time	Method
patients' satisfaction with advance directive is assessed as single items for reasons of parsimony: How much to you agree to the following statement: 'I am satisfied with my advance directive.' , which is assessed on a five-point Likert scale. It is assessed at both assessments T1 and T2.